Synonymous mutations in oncogenesis and apoptosis versus survival unveiled by network modeling

Synonymous mutations, which do not alter the encoded amino acid, have been routinely assumed to be ‘neutral’ and would have no effect on phenotype or fitness. Yet increasing observations have emerged to overturn this conventional concept. However, convicted elucidation of how synonymous mutations exert biological consequences in oncogenesis is still lacking. By performing systematic analysis of the TNF-α signaling network model, we identify the critical dose which separates the cell survival and apoptosis regions and define the sensitive parameters with single-parameter sensitivity analysis. Combining with the cancer-related mutation spectra obtained from 9 cancers, our results hint that, similar as missense and nonsense mutations, synonymous mutations are also strongly correlated with the parameter sensitivity of the critical dose, providing possible causal mechanism of the mutations in cancer development. Based on such a correlation, we furthermore dissect that members of caspases family proteases (caspase3, 6, 8) could jointly inhibit NFκB activation, providing efficient pro-apoptotic behavior. Thus, we argue that apoptosis module could suppress survival module through negative feedback of caspases family on NFκB.

[1]  Gary D Bader,et al.  Systematic identification of protein complexes in Saccharomyces cerevisiae by mass spectrometry , 2002, Nature.

[2]  Masakazu Toi,et al.  Nuclear factor-κB inhibitors as sensitizers to anticancer drugs , 2005, Nature Reviews Cancer.

[3]  J. M. Nicholson,et al.  Is carcinogenesis a form of speciation? , 2011, Cell cycle.

[4]  Nils Blüthgen,et al.  Mathematical Modeling Identifies Inhibitors of Apoptosis as Mediators of Positive Feedback and Bistability , 2006, PLoS Comput. Biol..

[5]  A. Barabasi,et al.  An empirical framework for binary interactome mapping , 2008, Nature Methods.

[6]  Lynne Pearce,et al.  Breaking the silence. , 2011, Nursing standard (Royal College of Nursing (Great Britain) : 1987).

[7]  B. Vogelstein,et al.  Variation in cancer risk among tissues can be explained by the number of stem cell divisions , 2015, Science.

[8]  A. Krainer,et al.  Listening to silence and understanding nonsense: exonic mutations that affect splicing , 2002, Nature Reviews Genetics.

[9]  R. Schwartz,et al.  Skeletal muscle myocytes undergo protein loss and reactive oxygen-mediated NF-κB activation in response to tumor necrosis factor α , 1998 .

[10]  D. Stupack Caspase-8 as a therapeutic target in cancer. , 2013, Cancer letters.

[11]  J. Plotkin,et al.  Synonymous but not the same: the causes and consequences of codon bias , 2011, Nature Reviews Genetics.

[12]  L. Rorke,et al.  Loss of caspase-8 protein expression correlates with unfavorable survival outcome in childhood medulloblastoma. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[13]  Stephen C. J. Parker,et al.  Whole-genome sequencing identifies a recurrent functional synonymous mutation in melanoma , 2013, Proceedings of the National Academy of Sciences.

[14]  J. Tavaré,et al.  Rapid caspase‐3 activation during apoptosis revealed using fluorescence‐resonance energy transfer , 2000, EMBO reports.

[15]  T. Nishiuchi,et al.  Mechanism and Repertoire of ASC-Mediated Gene Expression1 , 2009, The Journal of Immunology.

[16]  J. Tschopp,et al.  Loss of caspase-8 expression in highly malignant human neuroblastoma cells correlates with resistance to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis. , 2000, Cancer research.

[17]  G. Courtois,et al.  Inhibition of the NF-kappaB survival pathway via caspase-dependent cleavage of the IKK complex scaffold protein and NF-kappaB essential modulator NEMO. , 2008, Cell death and differentiation.

[18]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[19]  D. Lauffenburger,et al.  Quantitative analysis of pathways controlling extrinsic apoptosis in single cells. , 2008, Molecular cell.

[20]  Jianfeng Pei,et al.  Mutation-induced protein interaction kinetics changes affect apoptotic network dynamic properties and facilitate oncogenesis , 2015, Proceedings of the National Academy of Sciences.

[21]  Hanlee P. Ji,et al.  Multigene amplification and massively parallel sequencing for cancer mutation discovery , 2007, Proceedings of the National Academy of Sciences.

[22]  Albert-László Barabási,et al.  Scale-Free Networks: A Decade and Beyond , 2009, Science.

[23]  William Stafford Noble,et al.  Large-scale identification of yeast integral membrane protein interactions. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[24]  C. Kimchi-Sarfaty,et al.  Understanding the contribution of synonymous mutations to human disease , 2011, Nature Reviews Genetics.

[25]  A. Zernecke,et al.  Inhibition of inflammatory endothelial responses by a pathway involving caspase activation and p65 cleavage. , 2001, Biochemistry.

[26]  Jochen H M Prehn,et al.  Systems analysis of effector caspase activation and its control by X‐linked inhibitor of apoptosis protein , 2006, The EMBO journal.

[27]  G. Courtois,et al.  Inhibition of the NF-κB survival pathway via caspase-dependent cleavage of the IKK complex scaffold protein and NF-κB essential modulator NEMO , 2008, Cell Death and Differentiation.

[28]  C. Sonnenschein,et al.  The tissue organization field theory of cancer: A testable replacement for the somatic mutation theory , 2011, BioEssays : news and reviews in molecular, cellular and developmental biology.

[29]  R. Schwartz,et al.  Skeletal muscle myocytes undergo protein loss and reactive oxygen-mediated NF-kappaB activation in response to tumor necrosis factor alpha. , 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[30]  L. Hurst,et al.  The price of silent mutations. , 2009, Scientific American.

[31]  Michael Karin,et al.  NF-κB at the crossroads of life and death , 2002, Nature Immunology.

[32]  Jia Chen,et al.  Correlation between Oncogenic Mutations and Parameter Sensitivity of the Apoptosis Pathway Model , 2014, PLoS Comput. Biol..

[33]  L. Hurst,et al.  Hearing silence: non-neutral evolution at synonymous sites in mammals , 2006, Nature Reviews Genetics.

[34]  A. Baldwin,et al.  Apoptosis Promotes a Caspase-induced Amino-terminal Truncation of IκBα That Functions as a Stable Inhibitor of NF-κB* , 1999, The Journal of Biological Chemistry.

[35]  L. Hood,et al.  Activation of the NF-κB pathway by Caspase 8 and its homologs , 2000, Oncogene.

[36]  J. Schafer,et al.  Missing data: our view of the state of the art. , 2002, Psychological methods.

[37]  R. Ravi,et al.  CD95 (Fas)-induced Caspase-mediated Proteolysis of NF-κB , 1998 .

[38]  Gary D Bader,et al.  The human genome and drug discovery after a decade. Roads (still) not taken , 2011, 1102.0448.

[39]  Lippincott-Schwartz,et al.  Supporting Online Material Materials and Methods Som Text Figs. S1 to S8 Table S1 Movies S1 to S3 a " Silent " Polymorphism in the Mdr1 Gene Changes Substrate Specificity Corrected 30 November 2007; See Last Page , 2022 .

[40]  Grant W. Brown,et al.  Functional dissection of protein complexes involved in yeast chromosome biology using a genetic interaction map , 2007, Nature.

[41]  Chava Kimchi-Sarfaty,et al.  Exposing synonymous mutations. , 2014, Trends in genetics : TIG.

[42]  M. Lenardo,et al.  Caspase-8 Regulation by Direct Interaction with TRAF6 in T Cell Receptor-Induced NF-κB Activation , 2006, Current Biology.

[43]  E. Kandel,et al.  MicroRNA analysis suggests an additional level of feedback regulation in the NF-κB signaling cascade , 2015, Oncotarget.

[44]  L. Ouyang,et al.  Systems biology network-based discovery of a small molecule activator BL-AD008 targeting AMPK/ZIPK and inducing apoptosis in cervical cancer , 2015, Oncotarget.

[45]  Markus Rehm,et al.  Single-cell Fluorescence Resonance Energy Transfer Analysis Demonstrates That Caspase Activation during Apoptosis Is a Rapid Process , 2002, The Journal of Biological Chemistry.

[46]  A. Kieser,et al.  The adaptor protein FADD and the initiator caspase-8 mediate activation of NF-κB by TRAIL , 2012, Cell Death and Disease.

[47]  A. Hoffmann,et al.  The I (cid:1) B –NF-(cid:1) B Signaling Module: Temporal Control and Selective Gene Activation , 2022 .

[48]  Mingming Jia,et al.  COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer , 2010, Nucleic Acids Res..

[49]  B. Zhivotovsky,et al.  Caspases and cancer , 2011, Cell Death and Differentiation.

[50]  N. Perkins,et al.  The diverse and complex roles of NF-κB subunits in cancer , 2012, Nature Reviews Cancer.

[51]  H. Curtis Formal discussion of: somatic mutations and carcinogenesis. , 1965, Cancer research.

[52]  J C Reed,et al.  Pro-caspase-3 Is a Major Physiologic Target of Caspase-8* , 1998, The Journal of Biological Chemistry.

[53]  P. Scheurich,et al.  Tumor necrosis factor signaling , 2003, Cell Death and Differentiation.

[54]  Michael Karin,et al.  NF-kappaB at the crossroads of life and death. , 2002, Nature immunology.

[55]  A. Hoffmann,et al.  The IkappaB-NF-kappaB signaling module: temporal control and selective gene activation. , 2002, Science.

[56]  P. Chaudhary,et al.  An Evolutionary Conserved Pathway of Nuclear Factor-κB Activation Involving Caspase-mediated Cleavage and N-end Rule Pathway-mediated Degradation of IκBα* , 2004, Journal of Biological Chemistry.

[57]  R. Kassen,et al.  Adaptive synonymous mutations in an experimentally evolved Pseudomonas fluorescens population , 2014, Nature Communications.

[58]  J. Valcárcel,et al.  Synonymous Mutations Frequently Act as Driver Mutations in Human Cancers , 2014, Cell.

[59]  Frank Allgöwer,et al.  Heterogeneity reduces sensitivity of cell death for TNF-Stimuli , 2011, BMC Systems Biology.

[60]  S. Akira,et al.  Cutting Edge: Roles of Caspase-8 and Caspase-10 in Innate Immune Responses to Double-Stranded RNA , 2006, The Journal of Immunology.

[61]  Y. Lin,et al.  Cleavage of the death domain kinase RIP by caspase-8 prompts TNF-induced apoptosis. , 1999, Genes & development.

[62]  Ben Lehner,et al.  Tissue specificity and the human protein interaction network , 2009, Molecular systems biology.

[63]  Edward C Stites,et al.  Network Analysis of Oncogenic Ras Activation in Cancer , 2007, Science.

[64]  A. Knudson,et al.  Two genetic hits (more or less) to cancer , 2001, Nature Reviews Cancer.

[65]  M. Toi,et al.  Nuclear factor-kappaB inhibitors as sensitizers to anticancer drugs. , 2005, Nature reviews. Cancer.

[66]  E. Birney,et al.  Patterns of somatic mutation in human cancer genomes , 2007, Nature.

[67]  A. Butte,et al.  Non-Synonymous and Synonymous Coding SNPs Show Similar Likelihood and Effect Size of Human Disease Association , 2010, PloS one.

[68]  E. Birney,et al.  Patterns of somatic mutation in human cancer genomes , 2007, Nature.

[69]  J. Bertin,et al.  Caspase-8 and RIP kinases regulate bacteria-induced innate immune responses and cell death , 2014, Proceedings of the National Academy of Sciences.

[70]  L. Hood,et al.  Activation of the NF-kappaB pathway by caspase 8 and its homologs. , 2000, Oncogene.

[71]  R. Ozawa,et al.  A comprehensive two-hybrid analysis to explore the yeast protein interactome , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[72]  R. Schreiber,et al.  Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion , 2011, Science.

[73]  Sean R. Collins,et al.  Global landscape of protein complexes in the yeast Saccharomyces cerevisiae , 2006, Nature.

[74]  F. Behm,et al.  Caspase 8 is deleted or silenced preferentially in childhood neuroblastomas with amplification of MYCN , 2000, Nature Medicine.

[75]  P. Ao,et al.  Endogenous molecular network reveals two mechanisms of heterogeneity within gastric cancer , 2015, Oncotarget.

[76]  Bernhard O Palsson,et al.  The convex basis of the left null space of the stoichiometric matrix leads to the definition of metabolically meaningful pools. , 2003, Biophysical journal.

[77]  David Tollervey,et al.  Coding-Sequence Determinants of Gene Expression in Escherichia coli , 2009, Science.

[78]  M. Peter,et al.  The TNF Receptor 1 A Split Personality Complex , 2003, Cell.

[79]  K. Shokat,et al.  Human Catechol-O-Methyltransferase Haplotypes Modulate Protein Expression by Altering mRNA Secondary Structure , 2006, Science.

[80]  M. Boutros,et al.  Clustering phenotype populations by genome-wide RNAi and multiparametric imaging , 2010, Molecular systems biology.

[81]  Zhilin Qu,et al.  Regulation of the mammalian cell cycle: a model of the G1-to-S transition. , 2003, American journal of physiology. Cell physiology.

[82]  T. Pawson,et al.  Assembly of Cell Regulatory Systems Through Protein Interaction Domains , 2003, Science.

[83]  Roland Eils,et al.  Dynamics within the CD95 death-inducing signaling complex decide life and death of cells , 2010, Molecular systems biology.

[84]  L. Hood,et al.  Cancer as robust intrinsic state of endogenous molecular-cellular network shaped by evolution. , 2008, Medical hypotheses.

[85]  Benjamin J. Raphael,et al.  Mutational landscape and significance across 12 major cancer types , 2013, Nature.

[86]  R. Ravi,et al.  CD95 (Fas)-induced caspase-mediated proteolysis of NF-kappaB. , 1998, Cancer research.

[87]  James R. Knight,et al.  A comprehensive analysis of protein–protein interactions in Saccharomyces cerevisiae , 2000, Nature.

[88]  Yanhui Hu,et al.  Integrating protein-protein interaction networks with phenotypes reveals signs of interactions , 2013, Nature Methods.

[89]  M. Stratton,et al.  The cancer genome , 2009, Nature.

[90]  H. Horvitz,et al.  Phosphorylation of IκB-α Inhibits Its Cleavage by Caspase CPP32 in Vitro * , 1997, The Journal of Biological Chemistry.

[91]  E. Solary,et al.  Caspase-8 prevents sustained activation of NF-kappaB in monocytes undergoing macrophagic differentiation. , 2007, Blood.

[92]  J. Tschopp,et al.  Induction of TNF Receptor I-Mediated Apoptosis via Two Sequential Signaling Complexes , 2003, Cell.

[93]  J C Reed,et al.  A Single BIR Domain of XIAP Sufficient for Inhibiting Caspases* , 1998, The Journal of Biological Chemistry.

[94]  T. Seyfried,et al.  Cancer as a metabolic disease: implications for novel therapeutics , 2013, Carcinogenesis.

[95]  M. Kim,et al.  Caspase-3-mediated Cleavage of the NF-κB Subunit p65 at the NH2 Terminus Potentiates Naphthoquinone Analog-induced Apoptosis* , 2001, The Journal of Biological Chemistry.

[96]  H. Horvitz,et al.  Phosphorylation of IkappaB-alpha inhibits its cleavage by caspase CPP32 in vitro. , 1997, The Journal of biological chemistry.